Back to Article
Differential Complete Blood Count for Diagnosis of COVID-19?
World Journal of Medical Microbiology
| Vol 2, Issue 1
Table 2. Comparison ofPast Medical History between Case and Control Groups.
| Variable | Case Group | Control Group | Total | X2 Value | P Value (Sig) | |
| Gender | Male | 47 (54%) | 36 (41.9%) | 83 (48.0%) | 2.563 | 0.109 (NS) |
| Female | 40 (46%) | 50 (58.1%) | 90 (52.0%) | |||
| CND | +ve | 51 (58.6%) | 48 (55.8%) | 99 (57.2%) | 0.139 | 0.709 (NS) |
| +ve | 51 (58.6%) | 48 (55.8%) | 99 (57.2%) | |||
| DM | -ve | 48 (55.2%) | 49 (57.0%) | 97 (56.1%) | 0.057 | 0.811 (NS) |
| +ve | 39 (44.8%) | 37 (43.0%) | 76 (43.9%) | |||
| HTN | -ve | 58 (66.7%) | 51 (59.3%) | 109 (63.0%) | 1.006 | 0.316 (NS) |
| +ve | 29 (33.3%) | 35 (40.7%) | 64 (37.0%) | |||
| IHD | -ve | 82 (94.3%) | 81 (94.2%) | 163 (94.2%) | 0.000 | 0.985 (NS) |
| +ve | 5 (5.7%) | 5 (5.8%) | 10 (5.8%) | |||
| Stroke | -ve | 78 (89.7%) | 83 (96.5%) | 161 (93.1%) | 0.132 | 0.076 (NS) |
| +ve | 9 (10.3%) | 3 (3.5%) | 12 (6.9%) | |||
| Heart Failure | -ve | 83 (95.4%) | 80 (93.0%) | 163 (94.2%) | 0.449 | 0.503 (NS) |
| +ve | 4 (4.6%) | 6 (7.0%) | 10 (5.8%) | |||
| Anemia | -ve | 87 (100%) | 81 (94.2%) | 168 (97.1%) | 5.209 | 0.022 (Sig) |
| +ve | 0 (0%) | 5 (5.8%) | 5 (2.9%) | |||
NS: Non-Significant Sig: Significant.